These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


207 related items for PubMed ID: 32552774

  • 1. Evaluation of oral fluralaner (Bravecto®) for efficacy against nymphs of Amblyomma americanum and Rhipicephalus sanguineus (sensu lato).
    Allen K, Little S, Petersen M, Gruntmeir J, Barrett A, Herrin B, Starkey L, Sun F, Guerino F.
    Parasit Vectors; 2020 Jun 18; 13(1):315. PubMed ID: 32552774
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Year-round efficacy of a single treatment of fluralaner injectable suspension (Bravecto Quantum™) against repeated infestations with Rhipicephalus sanguineus (sensu lato) and Ctenocephalides felis in dogs.
    Fisara P, Guerino F.
    Parasit Vectors; 2023 Oct 23; 16(1):378. PubMed ID: 37872632
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative speed of kill of oral treatments with Simparica™ (sarolaner) and Bravecto®(fluralaner) against induced infestations of Rhipicephalus sanguineus on dogs.
    Becskei C, Geurden T, Liebenberg J, Cuppens O, Mahabir SP, Six RH.
    Parasit Vectors; 2016 Feb 24; 9():103. PubMed ID: 26911244
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Water immersion of dogs close to the time of topical fluralaner treatment does not reduce efficacy against a subsequent experimental challenge with Rhipicephalus sanguineus (sensu lato).
    Dongus H, Meyer L, Armstrong R.
    Parasit Vectors; 2017 Sep 25; 10(1):441. PubMed ID: 28946900
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Laboratory evaluations of the immediate and sustained efficacy of lotilaner (Credelio™) against four common species of ticks affecting dogs in North America.
    Murphy M, Garcia R, Karadzovska D, Cavalleri D, Snyder D, Seewald W, Real T, Drake J, Wiseman S, Nanchen S.
    Parasit Vectors; 2017 Nov 01; 10(1):523. PubMed ID: 29089057
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of fluralaner chewable tablets (Bravecto®) against Asian longhorned tick (Haemaphysalis longicornis) infestations of dogs.
    Petersen M, Maree R, Viljoen A, Liebenberg JE, Guerino F.
    Parasit Vectors; 2023 Feb 08; 16(1):60. PubMed ID: 36755268
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of fluralaner spot-on solution against induced infestations with Rhipicephalus sanguineus on dogs.
    Taenzler J, Liebenberg J, Mienie M, Everett WR, Young DR, Vihtelic TS, Sun F, Zschiesche E, Roepke RK, Heckeroth AR.
    Parasit Vectors; 2016 May 31; 9(1):276. PubMed ID: 27241176
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto (fluralaner) against Frontline (fipronil) in flea- and tick-infested dogs.
    Rohdich N, Roepke RK, Zschiesche E.
    Parasit Vectors; 2014 Mar 04; 7():83. PubMed ID: 24593931
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of two oral treatments for dogs containing either afoxolaner or fluralaner against Rhipicephalus sanguineus sensu lato and Dermacentor reticulatus.
    Beugnet F, Liebenberg J, Halos L.
    Vet Parasitol; 2015 Apr 15; 209(1-2):142-5. PubMed ID: 25716658
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.